Activase 50MG INJ 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FASWR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,469
Award facts
- Contract value 100% obligated
- $13,468.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,468.70 to AmerisourceBergen Drug Corp for the supply of Activase 50mg injection on December 18, 2025, with an ultimate completion date of January 16, 2026. This firm fixed-price contract, issued without set-aside provisions, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical procurement requirements through open competition, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for Activase represents the type of specific pharmaceutical product fulfillment that occurs regularly under the company's broader DLA prime vendor agreement, supporting military and veteran healthcare supply chain needs.
Quick answers
Who was awarded contract SPE2DR26FASWR?
SPE2DR26FASWR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FASWR worth?
The government has obligated $13,469 on SPE2DR26FASWR.
Is contract SPE2DR26FASWR an order under another contract?
Yes. SPE2DR26FASWR is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FASWR competed?
The extent of competition for SPE2DR26FASWR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award